May 2018 Vol 11, No 3

Is Adequate Nutrition Cost-Effective?

David B. Nash, MD, MBA

May 2018 Vol 11, No 3 - Editorial

Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis

Gilbert L. Queeley, PhD, Ellen S. Campbell, PhD

May 2018 Vol 11, No 3 - Clinical, Original Research

Stakeholder Perspective

Dialysis Procedures and Health-Related Quality of Life: The Challenge of Creating Evidence-Based Healthcare in End-Stage Renal Disease

by Michael F. Murphy, MD, PhD

Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States

Kathleen F. Villa, MS, Nancy L. Reaven, MA, Susan E. Funk, MBA, Karen McGaughey, PhD, Jed Black, MD

May 2018 Vol 11, No 3 - Business, Original Research

Stakeholder Perspective

Accurate Diagnosis of Chronic Diseases Can Reduce Costs and Medical Resource Utilization

by James T. Kenney, RPh, MBA

Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry

Dimitrios A. Pappas, MD, Robert A. Gerber, PharmD, MA, MBA, Heather J. Litman, PhD, David Gruben, PhD, Jamie Geier, PhD, Winnie D. Hua, MS, Connie Chen, PharmD, Youfu Li, MD, MPH, Joel M. Kremer, MD, John S. Andrews, MD, Jeffrey A. Bourret, PharmD

May 2018 Vol 11, No 3 - Clinical, Original Research

Stakeholder Perspective

Limited Guidelines and Treatment Success in the Current Standard of Care for Patients with Rheumatoid Arthritis Provide an Opportunity to Inform New Treatment Protocols

by Gary Branning, MBA

Results 1 - 4 of 4